DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, providing promising improvements across a variety of professional medical and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, far more reputable alternate for therapeutic use